Vaccine research efforts for filoviruses (Q35143290)

6 August 2017

Vaccine research efforts for filoviruses (English)

1 reference

6 August 2017

0 references

1 reference

Mary Kate Hart

1

1 reference

6 August 2017

1 May 2003

1 reference

International Journal for Parasitology

6 August 2017

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 August 2017

33

1 reference

6 August 2017

583-595

1 reference

6 August 2017

5-6

1 reference

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Inflammatory responses in Ebola virus-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

The pathology of experimental Ebola virus infection in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

The Ebola virus VP35 protein functions as a type I IFN antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Ebola haemorrhagic fever: experimental infection of monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

The role of the Type I interferon response in the resistance of mice to filovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

7 January 2021

Fighting the Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Pathogenesis of experimental Ebola virus infection in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Crystal structure of the matrix protein VP40 from Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Descriptive analysis of Ebola virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Marburg virus, a filovirus: méssenger RNAs, gene order, and regulatory elements of the replication cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Filovirus clearance in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Differentiation of filoviruses by electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Evaluation in nonhuman primates of vaccines against Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Marburg virus vaccines: comparing classical and new approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Preliminary report: isolation of Ebola virus from monkeys imported to USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Physicochemical Properties of Marburg Virus: Evidence for Three Distinct Virus Strains and Their Relationship to Ebola Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Marburg agent disease: In man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Recombinant human monoclonal antibodies to Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Respiratory Marburg virus infection in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

An analysis of features of pathogenesis in two animal models of Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

On the etiology of an unknown human infection originating from monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Fatal human disease from vervet monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Marburg-virus disease in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Infection and activation of monocytes by Marburg and Ebola viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Experimental inoculation of plants and animals with Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

The pathogenesis of Ebola hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Infectivity-enhancing antibodies to Ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Release of viral glycoproteins during Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Molecular characterization of guinea pig-adapted variants of Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Epitopes involved in antibody-mediated protection from Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Ebola virus: the search for vaccines and treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Immunization for Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

Ebola virus can be effectively neutralized by antibody produced in natural human infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900064-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7519(03)00064-X

1 reference

6 August 2017

1 reference

PubMed ID

12782057